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A colorimetric strategy based 
on dynamic chemistry for direct 
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species
Mavys tabraue-Chávez1, María Angélica Luque-González2,3, Antonio Marín-Romero1,2,3, 
Rosario María sánchez-Martín2,3, pablo escobedo-Araque  4, salvatore pernagallo1,5 & 
Juan José Díaz-Mochón1,2,3
Leishmaniasis and Chagas disease are endemic in many countries, and re-emerging in the developed 
countries. A rapid and accurate diagnosis is important for early treatment for reducing the duration 
of infection as well as for preventing further potential health complications. In this work, we have 
developed a novel colorimetric molecular assay that integrates nucleic acid analysis by dynamic 
chemistry (ChemNAt) with reverse dot-blot hybridization in an array format for a rapid and easy 
discrimination of Leishmania major and Trypanosoma cruzi. the assay consists of a singleplex pCR 
step that amplifies a highly homologous DNA sequence which encodes for the RNA component of the 
large ribosome subunit. The amplicons of the two different parasites differ between them by single 
nucleotide variations, known as “single Nucleotide Fingerprint” (sNF) markers. the sNF markers can 
be easily identified by naked eye using a novel micro Spin-Tube device "Spin-Tube", as each of them 
creates a specific spot pattern. Moreover, the direct use of ribosomal RNA without requiring the PCR 
pre-amplification step is also feasible, further increasing the simplicity of the assay. The molecular 
assay delivers sensitivity capable of identifying up to 8.7 copies per µL with single mismatch specificity. 
The Spin-Tube thus represents an innovative solution providing benefits in terms of time, cost, and 
simplicity, all of which are crucial for the diagnosis of infectious disease in developing countries.
Parasitic diseases not only cause millions of deaths per year, but also have serious health and economic conse-
quences1. Among all the parasitic diseases, protozoan parasites of the family Trypanosomatidae are responsi-
ble for devastating diseases in humans, dogs as well as livestock, resulting in severe illness or even death if left 
untreated1,2. The protozoa Trypanosoma cruzi (T. cruzi) and Leishmania spp. are the causative agents of Chagas 
disease and Leishmaniasis respectively3. Even though these diseases are endemic in tropical and sub-tropical 
regions of the world, in the last decades there has been a re-emergence also in developed countries, with inter-
national travel being responsible for increases in reported cases of Trypanosomatidae infections in non-endemic 
countries1,4. Consequently, these parasitic infections have become a more important public health issue of global 
relevance. Even though there are several methods available for the screening of parasitic infections, however, they 
have not yet changed dramatically the diagnosis in developing countries. Microscopic identification and parasite 
cultivation are still the primary diagnostic tools employed in many regions where Leishmaniasis is endemic5. 
These methods, unfortunately, require extended incubation times and are expensive, requiring specialized equip-
ment and highly trained personnel6. On the other hand, standard serological approaches that could potentially 
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prove to be timely and cost effective for diagnosing parasitic infections are of limited value, as most patients do 
not develop a significant antibody response7. In addition, and problematically for clinicians attempting to make 
an accurate diagnosis, T. cruzi and Leishmania spp. share various antigens that cause cross-reactivity in serologi-
cal diagnosis when complex antigenic mixtures are used8. As a result, Nucleic Acid Testing (NAT) methodologies 
have become valuable methods for the routine and accurate assessment of parasitic infectious diseases. NAT ben-
efits from the presence of specific nucleic acid fragments for determining the presence/absence of pathogens3,9–13. 
There are different methods ranging from probe hybridization, amplification of genomic targets and sequencing 
of nucleic acid fragments. The use of Nucleic Acid Amplification Techniques (NAATs) such as Polymerase Chain 
Reaction (PCR), real-time PCR or Nucleic Acid Sequence Based Amplification (NASBA) can be very useful 
in detecting infections and post-treatment monitoring9,13,14, including detection and distinguishing of parasites 
using single base resolution methods such as Single Base Extension (SBE). Primers are designed to hybridize to 
a complementary nucleic acid region such that the 3′ end of the primer finishes immediately before the nucleo-
tide under interrogation15. However, while NAT has the advantage of being sensitive, there are some limitations, 
as the NAT methodologies have complex protocols, require technical expertise to run and interpret data (not 
cost-effective), and utilize equipment that is incompatible with use in remote and low-resource locations, such as 
developing countries where diagnostic laboratories are often poorly resourced and sparsely distributed16. Thus, 
there is an urgent need for early detection of infectious disease with improved, simple and low-cost alternative 
tests not requiring expensive laboratory equipment to be performed. To sum up, while laboratory-based mod-
els require benchtop laboratory facilities and complex procedures, Point-of-Care testing allows a more decen-
tralized diagnostic analysis with additional advantages such as portability, automation, shorter time-to-results 
and lower cost17–19. The World Health Organization (WHO) is consistently encouraging developers to imple-
ment these new diagnostic technologies for improved effective clinical management and treatment of the major 
infections suitable in developing countries context20,21. These diagnostic devices should follow WHO criteria, the 
ASSURED acronym (affordable, sensitive, specific, user-friendly, rapid and robust, equipment-free and deliver-
able)22,23. Following this encouragement, Zhang et al. recently developed a low-cost CRISPR-based diagnostic 
(CRISPR-Dx) for detecting DNA or RNA molecules of pathogenic species with single mismatch specificity24,25.
Besides the tests available today19,26, our group has recently reported the successful detection and differentia-
tion of three Trypanosomatids species, by detecting Single Nucleotide Fingerprint (SNF) markers using a dynamic 
chemical approach for nucleic acid reading (ChemNAT technology)27,28 in combination with MALDI-ToF29. 
SNF markers are single nucleotide variations that occur at specific positions in conserved target nucleic acid 
sequences, allowing the differentiation of pathogenic species. As a result, these SNF represents the perfect target to 
be interrogated by the ChemNAT technology through the specific dynamic incorporation of aldehyde-modified 
SMART-Nucleobases into the abasic position of abasic PNA probes. Despite its high specificity, the use of this 
method has limitations, with higher cost and complex instrumentation (MALDI-ToF) required, making this 
approach unsuitable for diagnosis of parasitic infections in developing countries.
Here, we report the adaptation of our previous method onto a colorimetric reverse dot-blot30–35 assay that has 
the potential to fulfil the WHO ASSURED criteria, for the diagnosis of Leishmaniasis and Chagas disease. This 
novel method combines ChemNAT technology with a simple colorimetric end-point assay on a porous nylon 
membrane contained within a micro Spin-Tube device (Spin-Tube). The assay uses a singleplex PCR to amplify 
a highly conserved sequence of DNA, which encodes the RNA component of the large ribosome subunit with 
SNF markers for the two different parasite species under interrogation. This amplicon is later interrogated by the 
ChemNAT technology that relies on a dynamic chemical approach for nucleic acid testing. As shown in Fig. 1, 
the SNF sequence analysis is based on combining biotinylated aldehyde-modified cytosine (SMART-C-Biotin) 
with unique abasic PNA probes to target PCR amplicon strands, such that a nucleobase-free position on the PNA 
strand (known as ‘abasic’ position) lies opposite to two different nucleotides under interrogation on the DNA 
amplicons. A reversible reaction between the SMART-C-Biotin and a free secondary amine on the abasic PNA 
probes generates an iminium intermediate, which can be chemically reduced to a stable tertiary amine. Within 
the novel Spin-Tube, the dynamic chemistry reaction mixture is added to the nylon membranes on which the aba-
sic PNA probes have been immobilized following a specific spot pattern (Fig. 1, Step 1). The PCR amplicons act as 
template molecules and drive the specific incorporation of SMART-C-Biotin molecules into a specific abasic PNA 
according to Watson-Crick DNA base pairing model in which the SMART-Cytosine, in this case carrying a biotin 
tag, is ONLY recognized by a guanidine nucleotide (Fig. 1, Step 2). The labelling is then achieved by streptavi-
din alkaline phosphatase (Streptavidin-ALP) to produce colorimetric signal (blue precipitate) patterns when the 
chromogenic substrate (NBT/BCIP, nitro blue tetrazolium chloride/5-Bromo-4-chloro-3-indolyl phosphate) is 
added. Each parasite gives a unique colored spot pattern that can be read by naked-eye (Fig. 1, step 3).
Results and Discussion
Conserved region amplification and abasic probes design. PCR amplification was carried out to 
amplify the conserved region encoding for the 28S ribosomal RNA delta genes. As shown from the multiple 
sequence alignment in Fig. 2A, the PCR amplification of the target sequence was performed using a single pair 
of primers (singleplex PCR) which amplifies any of the parasite species present in the sample. The target region 
is highly conserved among the Trypanosomatids T. cruzi and L. major, except for five SNFs. Amplified fragment 
analysis was performed using the previously described Spin-Tube. Briefly, abasic PNA probes, PNA1 and PNA2 
were designed in order to hybridize efficiently with the amplified single strand sense DNA, with the impor-
tant particularity that the abasic positions in the PNA probes are opposing the nucleobases under interrogation. 
Once the abasic PNA probes hybridize with target sequences, the SMART-C-Biotin dynamic incorporation takes 
place, enabling the unequivocal identification of the parasite present in the amplicon sample, because of the 
unique colorimetric pattern that each Trypanosomatid amplicon generates. As shown in Fig. 2B, the abasic PNA1 
probe was designed so that its abasic site lies opposite a guanidine nucleotide (at position + 32 of the amplicon), 
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irrespective of the species, so as to give a positive result for both parasites, thus confirming the presence of one 
or both Trypanosomatids in the sample (see red arrow in Fig. 2A). At the same time, the abasic PNA2 is the 
probe that enables discrimination of the Trypanosomatid species. As the target parasite T. cruzi has a guanidine 
at the position that lines up with the “abasic” position in the abasic PNA2 probe (SNF1 in Fig. 2B), the SMART-
C-Biotin incorporation is templated, thereby covalently incorporating the biotin tag into the probe attached to 
the membrane, resulting in a blue spot after applying the labelling and color development protocol. DNA com-
ing from L. major has the same sequence but with an adenosine at the SNF1 position (instead of a guanine, see 
Fig. 2B). This DNA hybridizes with PNA2 but SMART-C-Biotin is not incorporated and so no signal is detected 
on abasic PNA2. In summary, this approach requires two specific molecular events to create a signal: (i) perfect 
hybridization between nucleic acid strands and complementary abasic PNA probes; and, (ii) specific molecular 
recognition, through guanidine-cytosine base-pairing to allow SMART-C-Biotin incorporation onto the abasic 
site of the PNA probes (Fig. 2C).
spin-tube fabrication. The ChemNAT technology with its colorimetric reverse dot blot assay (colorimetric 
ChemNAT assay) was integrated into a novel micro device, known as  “Spin-Tube” (Fig. 3A). As shown in Fig. 3B, 
the Spin-Tube consists of: (i) a centrifuge collection tube; (ii) an internal column for the assay; (iii) a nylon mem-
brane (pre-spotted with abasic PNA probes) immobilized onto the bottom of the column via a plastic pressure 
ring (iv). The abasic probes were amino-PEGylated at their N-terminal end and printed onto nylon membranes 
containing pre-activated carboxyl groups (Fig. 3C). An important stage in the construction of the Spin-Tube, 
apart from the immobilization of abasic PNAs, was the definition of the array probe layout (Fig. 3D). Probes with 
fixed concentrations were printed with an automatic nano-plotter onto the nylon membrane, and optimization 
of signal strength and best signal to background ratios was undertaken. Taking into account the 8 mm membrane 
diameter, it was decided to create a 2 × 3 array. Abasic PNA1 and PNA2 were printed onto two parallel rows of 
three spots each (6 features in total, in red and blue in Fig. 3D respectively). Two control biotin-labelled DNA 
oligomers were printed on the top row of the array, to identify array orientation and provide a labelling internal 
control (in yellow in Fig. 3D). Following printing, performance of probes was initially checked by using synthetic 
mimic DNA oligomers and SMART-C-Biotin incorporation (data not shown).
Abasic pNA probes design and synthesis. Abasic PNA1 and PNA2 were synthesized with 
amino-PEGylated groups in order to be covalently bonded and immobilized onto the solid substrate (nylon 
membranes). As previously described by our group, abasic neutral PNA probes immobilized onto solid surfaces 
have been found to lack stability and can exhibit a degree of undesirable deformation, flexing and/or bending36. 
This affects the performance (e.g., specificity and/or sensitivity) of the abasic PNA probes in this assay – prevent-
ing maximum target binding and assay performance. Abasic PNA1 and PNA2 were designed and synthesized 
with these solid surface challenges in mind, adding PNA monomers containing propanoic acid residues at their 
gamma positions across the probe backbone, improving the probe performance and reducing self-aggregation 
(Fig. 2B and Fig. S2 in SI). Moreover, these gamma modifications give rise to a sterocenter, hence creating chiral 
Figure 1. Spin-Tube assay: Merging of dynamic chemistry with a simple colorimetric end-point assay 
in a novel micro Spin-Tube device for analysing “Single Nucleotide Fingerprint” (SNF) markers. Step 1: 
modification of abasic PNAs, which are immobilized onto nylon membranes following specific spot patterns, 
with the biotinylated aldehyde-modified cytosine (SMART-C-Biotin). This process requires three steps: (i) 
perfect hybridization between abasic PNAs and PCR amplicons; (ii) generation of a reversible iminium specie 
between the secondary amine of the “abasic” unit and the aldehyde group of the SMART-C-Biotin nucleobase 
driven by the templating nucleobase. In this case, SMART-C-Biotin incorporation can be just templated by 
a guanidine as otherwise the iminium specie is not stable enough to be reduced; and (iii) reduction of the 
iminium specie by sodium cyanoborohydride to yield a non-reversible tertiary amine within the PNA printed 
onto the nylon membrane. Step 2: (iv) Biotin labelling with streptavidin alkaline phosphatase (Streptavidin-
ALP); (v) Incubation with the chromogenic substrate (NBT/BCIP, nitro blue tetrazolium chloride/ 5-Bromo-
4-chloro-3-indolyl phosphate) which generates a blue precipitate. Step 3: Data analyses by naked-eye reading. 
Time for the assay: 90 min PCR amplification; 60 min dynamic chemistry reaction; 30 min color development 
procedure, ±3 h total).
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PNAs molecules, being just the L-PNA monomers the ones producing PNA oligomers capable of hybridizing 
complementary natural nucleic acids37–40. The result was that the L-propanoic abasic PNA probes bound to nylon 
membrane were more readily available to hybridize to complementary nucleic acid strands. Still unknown was 
if such abasic PNA probes would prove to be less prone to flexing, bending or otherwise deforming from their 
“normal” linear configuration36. The modifications introduced led to the two probes demonstrating improved 
specificity and improved sensitivity towards a base complementary to the nucleobase of the DNA amplicon to be 
characterized. The abasic position monomer was also modified with this propanoic acid chain at gamma position 
and with the same stereochemistry allowing a better dynamic incorporation of the SMART-C-Biotin because of 
the spatial orientation of the free secondary amine of the “blank” position (Fig. S2 in SI).
Labelled sMARt Nucleobase for the colorimetric detection. While our previous mass spectrom-
etry method29 allowed parasite species detection and characterization by measurement of molecular weight 
differences between abasic PNA probes and aldehyde-modified nucleobases (SMART-Bases), in this Spin-Tube 
platform it was required that the SMART-Base were biotin-labelled (Figs S3–S5 in SI)41,42. Here the color develop-
ment reaction depends on the biotin recognition by a streptavidin-alkaline phosphatase complex, that transforms 
a colorless chromogenic substrate (NBT/BCIP, nitro blue tetrazolium chloride/5-Bromo-4-chloro-3-indolyl 
phosphate) into a blue precipitate each time there is a biotin tag attached to the membrane. The blue spots emerg-
ing correspond to those abasic PNA probes which have successfully hybridized with the complementary PCR 
products and in whose abasic positions SMART-C-Biotin has been incorporated through a guanosine template 
(Fig. 2). The SMART-C-Biotin bears a PEG spacer to increase water solubility while at the same time distancing 
the nitrogenous base involved in the hydrogen bonding recognition from the biotin tag responsible for the color 
development43.
Figure 2. (A) Multiple sequences alignment of L. major vs T. cruzi. Forward (highlighted in yellow) and 
reverse (highlighted in green) primers. Respectively, highlighted in red and blue, the abasic PNA1 and 
PNA2 complementary region in the PCR amplicon. Sequence alignment shows 5 SNFs (emphasized with 
orange rectangles). A red arrow indicates the guanidine “G” nucleotide at +32 from the 5′-terminus under 
interrogation via abasic PNA1 probe (emphasized also with a red rectangle), while the abasic PNA2 probe 
interrogates the first SNF (SNF1 emphasized with the blue rectangle). (B) Schemes of region of the PCR 
amplicons interrogated using the two abasic PNA probes. The chiral PNA monomers are identified with a star 
and highlighted in green. Incorporation of SMART-C-Biotin provides proof-reading, indicating the presence 
of the parasitic genome, as well as the discrimination between L. major vs T. cruzi. The white letters within the 
red and blue squares indicate the templating nucleotides that lie opposite the abasic position of PNA1 and PNA2, 
represented with the red or blue question mark respectively. (C) Each parasite gives rise to a specific SMART-C-
Biotin incorporation pattern. T. cruzi gives a positive result for both abasic probes, whereas L. major only shows 
a positive result in one, abasic PNA1.
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sequence analysis of genomic DNA. The Spin-Tube platform was validated using PCR products from 
genomic DNA (gDNA) of both parasites. Singleplex PCR was carried out to amplify the highly conserved segment 
of DNA containing the two single nucleotides under interrogation (Fig. 2). DNA amplicon products were dena-
tured and then together with the dynamic chemistry reaction reagents added directly into the internal column 
of the Spin-Tube that supports the nylon membrane for the color-development assay (Fig. 4). Subsequently, the 
reaction was carried out at a constant temperature of 45 °C avoiding the need to make use of sophisticated appa-
ratus. Single stranded DNA hybridizes with the abasic PNAs acting as template molecules, driving the error free 
incorporation of SMART-C-Biotin into the specific chemical pocket. Finally, the incorporated SMART-C-Biotin 
is labelled with a streptavidin-ALP, so that a colorimetric signal pattern was generated when the chromogenic 
substrate is added. The signal pattern generated by the protocol allows the visual or photographic imaging of 
which species cause the patient infection. L. major gDNA generated a signal ONLY at the abasic PNA1 probe, as 
its abasic site lies opposite a guanidine at +32 position from the 5′-terminus of amplicon (see red arrow in Fig. 2). 
While, T. cruzi gDNA generated signals for both abasic PNA probes. The abasic sites of both PNA probes lie 
opposite a guanidine, allowing the incorporation of SMART-C-Biotin with its biotin tag, thus resulting in a blue 
spot after its incorporation. Results in Fig. 4 show a successful identification of parasites present in samples, and 
in line with the expected results, showing (a) L. major positive for abasic PNA1 ONLY and (b) T. cruzi positive for 
both abasic PNA probes.
Assay specificity. Bioinformatic along with experimental analysis were carried out to discard the possibil-
ity that the presence of human gDNA on the samples could affect the singleplex PCR. Initially, a primer BLAST 
study was carried out using the NCBI primer BLAST tool and no human hits came out. Primers specificity against 
human gDNA was experimentally checked. 20 ng of human gDNA were used as PCR template for its amplification 
with the set of primers described in our study and neither colorimetric signals nor bands were detected using 
the Spin-Tube and capillary electrophoresis analysis respectively (Fig. 5, column 2: 2A and 2B), hence probing 
the specificity when human gDNA is present. We also mixed 20 ng of human gDNA with 20 ng of DNA from 
both Trypanosomatid species in order to perform PCR and amplicon analysis by capillary electrophoresis and 
Spin-Tube approaches (Fig. 5, column 3: 3A and 3B and column 4: 4A and 4B). It was confirmed that amplicon for-
mation of the Trypanosomatid species and their detection were not affected by the presence of the human gDNA.
In order to clarify the specificity of the PCR towards other microorganisms, an in silico study was carried 
out (data not shown). 28S ribosomal RNA delta gene sequences from Leishamania spp., Trypanosoma brucei 
and Trypanosoma cruzi were aligned using EMBL-EMI tool for multiple sequence alignment Clustal Omega to 
check that not only the primers but also the designed abasic PNA probes were suitable for the Spin-Tube and 
MALDI-ToF approaches. This tool was also used to study which other Leishmania species were suitable to be 
Figure 3. (A) Spin-Tube prototype; (B) Plastic components for the Spin-Tube fabrication (Fig. S1 in SI); (C) 
Amide formation between pre-activated carboxylic acid groups of nylon membranes and primary amine groups 
of abasic PNAs; (D) Graphic layout of the array: in yellow, 2 spots of biotin markers; in blue, 3 spots of abasic 
PNA2; in red, 3 spots of abasic PNA1.
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Figure 4. Steps of the Spin-Tube assay: (i) Samples collection (minutes) and nucleic acids extraction, either 
DNA (red) or RNA (green) (5 minutes); (ii) Singleplex PCR amplification of gDNA (90 minutes); (iii) Total 
RNA fragmentation (15 minutes); (iv) Biotin labelling by dynamic chemistry reaction. The reaction is carried 
out at 45 °C inside the internal column for the assay of Spin-Tube (60 minutes); (v) Washing with centrifuge 
(6000 rpm) and SMART-C-Biotin labelling with streptavidin-ALP (5 minutes); (v) Washing with centrifuge 
(6000 rpm) and addition of colorless chromogenic reagent to form a blue precipitate (8 minutes); (vi–vii) 
Washing and drying with centrifuge enable an unequivocal identification of the parasite present in the sample. 
Each parasite gives a unique colorimetric pattern: respectively (a) and (b) spot patterns for L. major and T. cruzi.
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submitted to this singleplex PCR. Forward and reverse primers were blasted towards other organisms using NCBI 
primer BLAST tool. It was found that mainly genome from Trypanosomatids species matched the designed prim-
ers. Although, a few other genome sequences could also be amplified by our designed primers (Schistosoma man-
soni, Leptomonas pyrrhocoris, Aspergillus sclerotioniger and Aspergillus eucalypticola), all these infectious agents 
cause diseases with clinical manifestations very different from those manifested in Leishmaniasis and Chagas 
disease and therefore other diagnostic paths would be proposed. Another key factor of the assay Spin-Tube is the 
signal emerges after the dynamic incorporation of SMART-C-Biotin into the abasic site of the abasic PNA probes. 
Even if off-target sequences are amplified, no colored spots will be observed. So, DNA strands coming from any 
off-target species will not create a signal, as that DNA strends will not have precise homology with both forward 
and reverse primers, as well as the region complementary to the abasic PNA within a narrow area of its genome.
Assay sensitivity. Clinically relevant sensitivity was achieved using the amplification and detection plat-
form. The assay was challenged by interrogating different PCR amplification reactions, using decreasing amounts 
of T. cruzi gDNA as starting material. Important to note in this study, 3 biotin markers were printed on the top 
row of the array, rather than 2 (Fig. 6A). Instead of simple circular plastic-ring (see red arrow in Fig. S1-D in 
SI), here for the construction of Spin-Tube, pressure plastic-ring with three plastic teeth (see white arrow in 
Fig. S1-D in SI) were used. Six different amounts of gDNA (50 ng, 5 ng, 0.5 ng, 0.05 ng, 0.005 ng, 0.0005 ng) were 
studied (Table S1 in SI). PCR amplifications were validated and quantified by capillary electrophoresis. All but 
the two lowest amounts of gDNA (0.005 ng and 0.0005 ng) produced amplicons which were able to be detected 
and quantified by capillary electrophoresis (Fig. 6B). The amplification products were then used as template for 
the dynamic incorporation of SMART-C-Biotin within the Spin-Tube. Positive signals were obtained for both 
abasic PNAs as anticipated, confirming the presence of T. cruzi (Fig. 6C).
A relative quantification of the signal intensity was carried out using ImageJ software. Average background 
signal intensity was taken and subtracted from all the measurements. Biotin signal intensity (marker) was used as 
reference representing 100% intensity. The signal intensity for each abasic PNA probe was extracted and expressed 
as a percentage of the biotin signal. Almost no difference was observed by eye for the membranes in which 50 
and 5 ng of T. cruzi gDNA was used as template for the PCR, whereas the relative signal intensity quantification 
Figure 5. (A) Capillary electrophoresis and (B) colorimetric results. First row shows the template used for 
the PCR reaction (1 to 4). Second and third rows show the capillary electrophoresis results (1A to 4A). Fourth 
and fifth rows show the colorimetric results (1B to 4B). Regarding columns: Column 1 corresponds to the PCR 
negative control (water) showing the absence of PCR contamination (1A) and the look of the membrane after 
all the procedure with just the biotin positive control of the colorimetric assay (1B). Column 2 shows the PCR 
performed on 20 ng of human gDNA highlighting the specificity of the previously designed primers (2A and 
2B). Column 3 matches with the PCR performed on 20 ng of T. cruzi gDNA sample that has been mixed with 
an equal amount of human gDNA (3A and 3B) and column 4 shows the experiment carried out on 20 ng of L. 
major gDNA samples mixed with other 20 ng of human gDNA (4A and 4B).
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by ImageJ software showed a slight lowering of signal as the genomic amounts decreased (Fig. 6C). The lowest 
point which could be detected was 0.05 ng or 8.7 copies/µL of template (see SI, Table S1 for the correlation of ng of 
gDNA and copy number). No results were observed for the two lowest genomic quantities, respectively 0.05 and 
0.005 ng. These results confirm what had been already observed using capillary electrophoresis, further confirm-
ing that the limit of detection of the dynamic incorporation assay depends on the PCR yield to provide sufficient 
template. Reactions in which not enough copies of amplicons were created were mis-called as parasite free, being 
false negatives. Negative control (made with H2O as template for the PCR) was also called as parasite free, being 
a true negative result.
Analysis of spiked parasite gDNA in blood. Verma et al. in their previous study44 reported a mean 
Leishmania parasite load of 8,372 parasites/mL in a group of 29 visceral leishmaniasis patients. In order to deter-
mine if the sensitivity of the Spin-Tube is able to detect the levels of infections reported by Verma et al., a spike-in 
Figure 6. (A) Spotting layout with 3 Biotin marker spots (yellow) rather than the 2 of Fig. 3D. 3 spots of PNA1 
(red) and 3 spots of PNA2 (blue). (B) Agilent Bioanalyzer 2100 gel-like images extrapolated from the capillary 
electrophoresis for the PCR products of T. cruzi. These gel-like images are produced from the chromatogram 
of the capillary electrophoresis by the bioanalyzer analysis software. NC: negative control PCR (water); 1–6 
PCR reactions using decreasing amounts of gDNA of T. cruzi. 1: 50 ng; 2: 5 ng; 3: 0.5 ng; 4: 0.05 ng; 5: 0.005 ng; 
6: 0.0005 ng. (C) Decreasing amounts of PCR products were used as templates for the dynamic chemistry 
reaction to incorporate the SMART-C-Biotin. Positive signals were obtained on both abasic PNA probes with 
PCR starting concentration from 50 ng up to 0.05 ng (8.7 copies/µL) of template what coincides with the last 
PCR product that was able to be detected by capillary electrophoresis. A percentage of the relative intensity was 
calculated using as 100% signal the average of the three biotin marker spots.
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experiment was performed. Two human blood samples were spiked-in with 10 and 0.1 ng of L. major gDNA and 
total DNA was extracted. Those extracted DNAs were used as template for PCR amplifications and the gener-
ated amplicons were analyzed by capillary electrophoresis (Fig. 7A) and by the Spin-Tube (Fig. 7B). The results 
confirmed that the Spin-Tube is able to detect a minimum of 0.1 ng of L. major gDNA spiked-in 200 μL of whole 
blood that equals to 5,000 parasite per mL of blood according the previous publication44.
Direct sequence analysis of ribosomal RNA. Since the target nucleic acid of the assay was the sense 
strand DNA of the gene coding for the 28S rRNA delta unit, RNA could also be used as a target nucleic acid 
using the dynamic chemistry approach (Fig. 8A). Recently, the dynamic chemistry approach was used to quantify 
circulating miRNAs41, demonstrating its feasibility to detect both DNA and RNA molecules. Direct detection 
of ribosomal RNA would avoid performing DNA pre-amplification steps by PCR and denaturation and could 
significantly simplify and shorten the protocol. This would allow its implementation in developing and 
resources-limited countries.
A proof-of-concept study was carried out using RNA as the templating nucleic acid. Total RNA from both 
parasites L. major and T. cruzi was used. RNA quality and quantitation were determined using an Agilent 2100 
Bioanalyzer and RNA 6000 Nano kit (Fig. S7 in SI). Total RNA was fragmented enzymatically, breaking down 
RNA strands into small segments to facilitate the subsequent hybridization with complementary abasic PNA 
probes. RNA fragmentation was checked using RNA Pico kit on an Agilent 2100 Bioanalyzer as shown in SI, 
Fig. S8. Dynamic incorporation of SMART-C-Biotin was performed using 10 µM of SMART-C-Biotin and 1 mM 
of sodium cyanoborohydride for 1 hour. The results obtained coincided with those obtained when using PCR 
products. L. major gave positive results for PNA1 and T. cruzi provided a positive signal for both PNA probes 
(Fig. 8B). This was a breakthrough achievement, demonstrating for the first time that direct, PCR free parasite 
identification from RNA samples was achieved. In addition, a much shorter protocol was developed while at the 
same time reducing the possibility of cross-contamination. This demostrated  that RNA can also be considered as 
a biomarker source for the ChemNAT approach and a future application of the Spin-Tube.
Figure 7. Analysis of spiked parasite gDNA in blood. (A) Capillary electrophoresis and (B) Spin-Tube results. 
First row indicate the template used for the PCR reaction (1 to 4). Second and third rows show the capillary 
electrophoresis results (1A to 4A). Fourth and fifth rows show the Spin-Tube results (1B to 4B). Regarding 
columns: Column 1 corresponds to the PCR negative control showing the absence of contamination (1A) 
and the look of the membrane after all the colorimetric procedure with just the biotin positive control of 
the colorimetric assay (1B). Column 2 shows the PCR performed on 450 ng of DNA extracted from 200 µL 
of human blood which highlights the specificity of the previously designed primers and the absence of false 
negatives due to the presence of human blood and DNA (2A and 2B). Column 3 contains the PCR performed 
on 450 ng of DNA extracted from 200 µL of human blood spiked-in with 10 ng of L. major gDNA (3A and 
3B) and column 4 shows the results of the experiment carried out with a PCR performed on 450 ng of DNA 
extracted from 200 µL of human blood spiked-in with 0.1 ng of L. major gDNA (4A and 4B).
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Material and Methods
General. All chemicals were obtained from Sigma Aldrich and used as received. SCD buffer was prepared 
from 2x saline sodium citrate (SSC) and 0.1% sodium dodecyl sulphate (SDS) with the pH adjusted to 6.0 using 
HCl. All synthetic DNA oligomers (desalted) were purchased from Microsynth AG (Balgach, Switzerland). The 
two abasic PNA probes (Abasic PNA1 and PNA2) were synthesized by DestiNA Genomica SL (Spain) using 
standard solid-phase synthesis techniques on an Intavis Bioanalytical Instruments MultiPrep CF Synthesizer 
(Intavis AG GmH, Germany). Aqueous solutions of abasic PNA probes were prepared and concentrations were 
determined using a NanoDrop ND-1000 spectrophotometer version 3.3.1. (Thermo Fisher Scientific) using as 
extinction coefficient values (Ɛ260) either 6.6, 8.8, 13.7 and 11.7 (mM−1 cm−1) for C, T, A, G, respectively. SMART-
C-Biotin was prepared by DestiNA Genomica SL (Spain) as reported elsewhere28. Buffers and dilution reagents 
were provided by Master Diagnostica SL (Spain). The composition of reagents I to VI is property of Vitro SA 
(Spain).
Genomic DNA samples. Parasitic protozoa genomic DNAs (gDNAs) were purchased from the American 
Type Culture Collection (ATCC). Respectively, gDNA from T. cruzi strain Tulahuen with ATCC ID 30266D and 
gDNA from L. major with ATCC ID 30012D. Human gDNA was extracted from MUM-2B cell line provided by 
J.C. Rodríguez-Manzaneque’s laboratory.
target nucleic acid selection. Multiple sequence alignment of the 28S rRNA delta genes of L. major vs. T. 
cruzi was carried out using the Clustal Omega, a free on-line available multiple sequence alignment tool offered 
by EMBL-EBI.
BLAST studies were carried out with the NCBI primer BLAST tool (https://www.ncbi.nlm.nih.gov/tools/
primer-blast/primertool.cgi?ctg_time=1534265329&job_key=NT_qawTpCUEufxN6Hho3SGQBJnpJEj1nSA).
PCR Amplification. Alignment results were used to design a single pair of primers able to amplify the tar-
get region of both parasites. Primers (5'-3') sequences were: Forward: GATTGTGAAGGGATCTCGCAG and 
Reverse: TCTGGCTTAGAGGCGTTCA. PCR amplification was performed on a Veriti 96-well Thermal cycler 
(Thermo Fisher Scientific). Cycling conditions for PCR were as follows: (1) initial denaturation at 96 °C for 3 min; 
(2) 40 cycles of (a) denaturation 96 °C for 30 sec, (b) annealing at 61 °C for 30 sec, and (c) extension at 72 °C for 
30 sec; (3) final extension at 72 °C for 10 sec; (4) final hold at 4 °C. 5 µL of gDNA solutions containing different 
amounts of gDNA solution for L. major or T. cruzi were amplified using 1X PCR master mix (Thermo Fisher 
Scientific), 0.15 µM forward and reverse primers per reaction with a final volume of 50 µL. DNA templates were 
replaced with water for negative controls. PCR reactions were confirmed by capillary electrophoresis using the 
Agilent 2100 Bioanalyzer and DNA 1000 Kit.
RNA fragmentation. RNA was extracted from parasites as described elsewhere45. RNA quality assessment 
and quantitation were determined using the Agilent 2100 Bioanalyzer and RNA 6000 Pico Kit (Fig. S7 in SI). 
NEBNext Magnesium RNA Fragmentation Module Protocol was used to fragment RNA. The following reagents 
were mixed in a sterile PCR tube: 1–18 µL of purified RNA containing 2–50 µg of total RNA, 2 µL of RNA frag-
mentation buffer and complete with nuclease-free water up to 20 µL. The mixture was incubated at 94 °C for 
5 minutes (to get fragments of around 200-mer length). Then the tube was transferred to ice and 2 µL of RNA 
Fragmentation stop solution were added. The fragmented RNA was cleaned up using ethanol precipitation: 22 µL 
of fragmented RNA, 2 µL of 3 M sodium acetate pH 5.2 and 60 µL of 100% ethanol. The mixture was incubated 
at -80 °C for 30 minutes and then centrifuged at 14,000 r.p.m. for 25 minutes at 4 °C and ethanol was removed 
carefully. The pellet was washed with 300 µL of 70% ethanol, centrifuged and removed the ethanol. Finally, the 
pellet was air-dry for up to 10 minutes at room temperature and re-suspended in 13.5 µL of nuclease-free water. 
To assess the yield and size distribution of the fragmented RNA, 1 µL of a 10-fold dilution was analyzed using the 
Agilent 2100 Bioanalyzer and RNA 6000 Pico Kit analysis (Fig. S8 in SI).
Figure 8. (A) Scheme for the synthesis of ribosomal RNA (sense RNA). The sense RNA is transcribed from the 
anti-sense DNA strand by RNA polymerase. The sense RNA strand templates the dynamic chemistry reaction 
containing both the guanidine “G” and the SNF1 for templating the SMART-C-Biotin incorporation respectively 
in the abasic PNA1 and PNA2 probes. (B) Unique colorimetric patterns both for L. major and T. cruzi.
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Abasic pNA probes spotting. An automatic immobilization of the probes on the membranes was done using 
Personal Arrayer 16 (CapitalBio Corporation, China). Immunodyne ABC Membrane was purchased from Pall 
Corporation (US). Abasic PNA probe spotting solutions were prepared to have the following final reagents concen-
trations 0.2025 mg/mL amaranth dye, 0.125 M sodium bicarbonate, 30% of DMSO and 15 µM abasic PNA probe.
spin-tube: sMARt-C-Biotin dynamic incorporation reaction on membranes and colorimetric 
readout. Reaction mixtures with a final volume of 300 µL were prepared by mixing: 45 µL of PCR products, 
15 µL of SMART-C-Biotin (200 µM), 20 µL of sodium cyanoborohydride (NaBH3CN) - 15 mM in water, and 
220 µL of SCD buffer. Protocol: All steps were performed using 300 µL and Spin-Tube devices were centrifuged 
to discard the solutions between each step. Membranes were incubated for 2 minutes at 45 °C with 300 µL of SCD 
buffer. The reaction mixture was added and incubated at 45 °C for 60 minutes. Upon completion of the incuba-
tion, three post-reaction washing steps were carried out using reagent I (pre-heated at 45 °C). This was followed 
by a blocking step in which membranes were incubated with reagent II for 5 minutes at RT. The enzymatic reac-
tion was carried out by incubating the membranes with reagent III at RT for 5 minutes. Four post-enzymatic 
reaction washing steps with reagent IV were carried out. The chromogen solution (reagent V) was added to the 
membranes and left at 41 °C for 5 minutes. Finally, three post-chromogen washing steps with reagent VI were 
carried out. Membranes were able to be analyzed.
Sensitivity and specificity of the assay. To assess the specificity of the assay, four tests were carried out: 
(1) one in which the PCR contained water instead of gDNAs and (2) another one in which 20 ng of human gDNA 
was used as template; and two more tests in which 20 ng of human gDNA were mixed with other 20 ng of each 
parasite (Fig. 5). On the other hand, for the sensitivity study, a range of PCR amplification reactions were per-
formed using decreasing amounts of starting T. cruzi gDNA. Six different concentration points (10-fold dilutions) 
plus a negative control (water) were used in triplicate. All PCR amplification products were analyzed by capillary 
electrophoresis to determine the amount, if any, of amplicon had been generated (Fig. 5 for specificity and Fig. 6 
and Table S1 for sensitivity). Expected size of amplicons were detected when the PCR was performed using the 
four highest amount of parasitic gDNAs while no bands were detected neither when using just human gDNA nor 
when using 0.1 and 0.01 pg/µL (Fig. 6B). Negative control (water) has not shown any signal, being truly a negative 
and so being effectively called as parasite free.
L. major gDNA spike-in experiments on blood. DNA was extracted from 200 µL of human whole blood 
samples using QIAamp DNA Blood mini kit (Qiagen, Germany) following manufacturer’s guidelines. After pro-
teinase K treatment, two samples were spiked with 10 and 0.1 ng of L. major gDNA. Then, the next steps of the 
DNA extraction protocol were followed as recommended. Samples were eluted in 30 µL of elution buffer AE. 
DNA was quantified with NanoDrop ND-1000 spectrophotometer version 3.3.1. (Thermo Fisher Scientific). PCR 
reactions were performed with a fix amount of DNA, 450 ng. After that, PCR were analyzed by capillary electro-
phoresis (using the Agilent 2100 Bioanalyzer and DNA 1000 Kit) and by the Spin-Tube.
Conclusions
Our previous SNF sequence analysis by mass-based assay (MALDI-ToF) for trypanosomiasis identification 
has been further developed onto a new ultra-low-cost, easy and fast to use (~3 hours/test) Spin-Tube device. 
This novel device was designed to combine the dynamic chemical approach for nucleic acid reading (ChemNAT 
technology) with a colorimetric method in a plastic column and nylon membrane device (Spin-Tube). The 
Spin-Tube accurately distinguish and identify Chagas disease vs. Leishmaniasis. The test consists of a singleplex 
PCR to amplify a highly conserved sequence of DNA, that encodes the RNA component of the large ribosome 
subunit containing SNFs from the two different parasite species under interrogation. Amplicon identification 
to single base resolution was achieved. Dynamic chemistry enables preformans in a simple Spin-Tube. The assay 
allows for a naked-eye read-out of the unique colorimetric patterns coming for sample analysis. Clinical treat-
ment decisions can be made without any ancillary equipment. The proposed Spin-Tube assay not only allows 
the detection of the presence of Trypanosomatid pathogens, but also differential diagnosis of Leishmaniasis vs. 
Chagas disease. Multiplexing is achieved by coupling various target-specific abasic probes onto nylon membranes 
using different array layouts and patterns. Incorporation of SMART-Biotin only into target sequences ensure high 
specificity. Clinically relevant sensitivity was obtained using our amplification and detection platform, down to a 
level of detection of 0.001 ng/µL (8.7 copies per µL) of gDNA from pathogen. Moreover, 0.1 ng of L. major gDNA 
was successfully detected when spiked-in with human blood samples. The assay has demonstrated a clinically 
relevant sensitivity and specificity44. A remarkable achievement was for the first time to succeed in the direct 
detection of ribosomal RNA. It opens up the possibility for direct detection of Trypanosomatids from biolog-
ical fluids without any pre-amplification or pre-labelling of target nucleic acids. This breakthrough provides a 
prototype assay for an innovative PCR free product with many inherent benefits such as lower cross-contamination 
risk, simplification of protocol, reduction of time-to-results, significantly lower cost, to insure far lower risk of 
assay result errors. Concluding, we believe that the Spin-Tube developed by our group provides an accurate tool 
conbianing high sensitivity and specificity, permitting rapid identification and differential diagnosis of Chagas 
disease and Leishmaniasis. Its clinical value will be an improved patient monitoring and therapeutic decision 
making. The Spin-Tube opens-up the promise of repertoire of assays for other infectious diseases, such as malaria 
and tuberculosis.
Data Availability
All data and information are available upon request.
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